Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by legaleafson Dec 22, 2019 2:04pm
207 Views
Post# 30481671

I first bought ACB in Dec 2016 at $2.08....

I first bought ACB in Dec 2016 at $2.08....I bought into ACB because I had high hopes for this new industry. I really thought that this was the new green gold rush....and financially, especially in 2016/17&18, it was. I bought and sold many times and I am very thankful to have made some really nice gains back in the green rush. Very thankful. 

I am also personally very familiar with MJ, and I have been a regular daily user of it for many years now, and truly know all the benefits it has to offer me. I love it, and will continue to use it daily for the rest of my life.....so naturally, I thought that if I loved the product so much, well then certainly other people will love it as well....and sure enough, many do. There is no question that it is very popular for a multitude of reasons. Thats all good and fine. MJ is here to stay, and I think that is a wonderful thing.

I also liked ACBs business model and was with them almost every step of the way. I say "almost" because  I did NOT support the Cannimed deal, nor did I support the Medrelief deal.....only because as a corporate lawyer for Canadas second largest grocery chain, it was easy for me, (and the vast majority of my colleagues)  to see that the price being paid for those two aquisitions was simply too high....but that is a whole other story. I still happily continued to support  ACB as this was a brand new industry. Completely new territory. 

I was very patient with ACB and let all the milestones that they promised would bring us great fortunes come to fruition.I accepted the heavy dillution as a nessesary evil etc etc.I was in for the perverbial long-haul. 

As anyone can see from my posting history, that I NEVER bashed ACB, not one time, and actually spent a lot of time defending them and their/my vision. 

Fast forward to nearly ALL 2019 financials for all LPs and it is as clear as crystal that the Canadian/International markets are simply not as big as I, and many others, had thought it would be...not by a long shot. Yes, it is still a young industry, and yes it will take time to work through the growing pains and so on, but almost every MJ company is now  in the same boat...showing massive losses, slowing growth, and shrinking margins.

In the world of corporate finance, that is the Trifecta Of Death.

Folks, the numbers are simply not there. I am fully aware of the challenges we have faced and continue to face as an industry, and it would be easy to point fingers at everything and everyone as to WHY the rollout lacked, the overblown vaping crisis, heavy Government restrictions  and so on, but facts are facts.  

Many of us were simply wrong. 




Bullboard Posts